VOLUME
67 2006 NUMBER 1
Editorial
5 Focus on Childhood and Adolescent Mental Health. Melissa P. DelBello
[PDF]
Commentary
7 The Impact of Disasters and Their Aftermath on Mental Health.
[CME] Robert J. Ursano, Frederick P. Cerise, Robert DeMartino, Dori B.
Reissman, and M. Katherine Shear
[PDF]
Original Articles
15 High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for
Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial. Philip T. Ninan, Lorrin M. Koran, Ari Kiev, Jonathan R. T. Davidson,
Steven A. Rasmussen, John M. Zajecka, Delbert G. Robinson, Paul
Crits-Christoph, Francine S. Mandel, and Carol Austin
[Abstract]
[PDF]
23 Prevalence and Severity of Intimate Partner Violence and Associations
With Family Functioning and Alcohol Abuse in Psychiatric Inpatients With
Suicidal Intent.
[CME] Alison M. Heru, Gregory L. Stuart, Samara Rainey, Jody Eyre, and
Patricia Ryan Recupero
[Abstract]
[PDF]
30 Botulinum Toxin Treatment of Social Anxiety Disorder With
Hyperhidrosis: A Placebo-Controlled Double-Blind Trial. Kathryn M. Connor, Jonathan L. Cook, and Jonathan R. T. Davidson
[Abstract]
[PDF]
37 Validity of the Impact Factor of Journals as a Measure of Randomized
Controlled Trial Quality. Corrado Barbui, Andrea Cipriani, Lara Malvini, and Michele Tansella
[Abstract]
[PDF]
41 Remission of Generalized Anxiety Disorder: A Review of the Paroxetine
Clinical Trials Database. Karl Rickels, Moira Rynn, Malini Iyengar, and David Duff
[Abstract]
[PDF]
48 Are Antidepressants Associated With New-Onset Suicidality in Bipolar
Disorder? A Prospective Study of Participants in the Systematic Treatment
Enhancement Program for Bipolar Disorder (STEP-BD). Mark S. Bauer, Stephen R. Wisniewski, Lauren B. Marangell, Cheryl A.
Chessick, Michael H. Allen, Ellen B. Dennehy, David J. Miklowitz, Michael E.
Thase, and Gary S. Sachs, for the STEP-BD Investigators
[Abstract]
[PDF]
56 Nativity and DSM-IV Psychiatric Disorders Among Puerto Ricans, Cuban
Americans, and Non-Latino Whites in the United States: Results From the
National Epidemiologic Survey on Alcohol and Related Conditions. Margarita Alegria, Glorisa Canino, Frederick S. Stinson, and Bridget
F. Grant
[Abstract]
[PDF]
66 Open-Label Tiagabine Monotherapy for Major Depressive Disorder With
Anxiety. Linda L. Carpenter, Jordan M. Schecter, Audrey R. Tyrka, Andrea F.
Mello, Marcelo F. Mello, Ryan Haggarty, and Lawrence H. Price
[Abstract]
[PDF]
72 Venlafaxine Extended Release in the Short-Term Treatment of Depressed
and Anxious Primary Care Patients With Multisomatoform Disorder. Kurt Kroenke, Nicholas Messina III, Isma Benattia, Jay Graepel, and
Jeff Musgnung
[Abstract]
[PDF]
81 An Open Trial of Adjunctive Escitalopram in Bipolar Depression. Manoela Fonseca, Jair C. Soares, John P. Hatch, Aida P. Santin, and
Flavio Kapczinski
[Abstract]
[PDF]
87 Psychiatric Phenotype of the Fragile X-Associated Tremor/Ataxia
Syndrome (FXTAS) in Males: Newly Described Fronto-Subcortical Dementia. Susan Bacalman, Faraz Farzin, James A. Bourgeois, Jennifer Cogswell,
Beth L. Goodlin-Jones, Louise W. Gane, Jim Grigsby, Maureen A. Leehey, Flora
Tassone, and Randi J. Hagerman
[Abstract]
[PDF]
95 Differential Efficacy of Olanzapine and Lithium in Preventing Manic or
Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of
Previous Manic or Mixed Episodes. Terence A. Ketter, John P. Houston, David H. Adams, Richard C. Risser,
Adam L. Meyers, Douglas J. Williamson, and Mauricio Tohen
[Abstract]
[PDF]
102 The Association Between Moderate Alcohol Use and Illness Severity in
Bipolar Disorder: A Preliminary Report. Benjamin I. Goldstein, Vytas P. Velyvis, and Sagar V. Parikh
[Abstract]
[PDF]
107 Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients
With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials. Patrizia A. Cavazzoni, Paul H. Berg, Ludmila A. Kryzhanovskaya, Susan
D. Briggs, Tamra E. Roddy, Mauricio Tohen, and John M. Kane
[Abstract]
[PDF]
Focus on Childhood and Adolescent Mental Health
114 The Past, Future, and Present of Childhood and Adolescent Mental
Health. Melissa P. DelBello
[PDF]
115 The Health Care Crisis of Childhood-Onset Bipolar Illness: Some
Recommendations for Its Amelioration. Robert M. Post and Robert A. Kowatch
[Abstract]
[PDF]
126 Children of Currently Depressed Mothers: A STAR*D Ancillary Study. Daniel J. Pilowsky, Priya J. Wickramaratne, A. John Rush, Carroll W.
Hughes, Judy Garber, Erin Malloy, Cheryl A. King, Gabrielle Cerda, A. Bela
Sood, Jonathan E. Alpert, Stephen R. Wisniewski, Madhukar H. Trivedi,
Ardesheer Talati, Marlene M. Carlson, Harry Hong Liu, Maurizio Fava, and
Myrna M. Weissman
[Abstract]
[PDF]
137 Modafinil Film-Coated Tablets in Children and Adolescents With
Attention-Deficit/Hyperactivity Disorder: Results of a Randomized,
Double-Blind, Placebo-Controlled, Fixed-Dose Study Followed by Abrupt
Discontinuation. James M. Swanson, Laurence L. Greenhill, Frank A. Lopez, Andrew
Sedillo, Craig Q. Earl, John G. Jiang, and Joseph Biederman
[Abstract]
[PDF]
Academic Highlights
148 New Developments in the Treatment of ADHD. [CME]
[PDF]
ASCP CORNER
160 Real-Life Switching Strategies With Second-Generation Antipsychotics. Christoph U. Correll
[PDF]
Letters To the Editor
162 Methodological Issues in a Comparative Study of Ziprasidone and
Risperidone. Georges M. Gharabawi, Cynthia A. Bossie, Ramy Mahmoud, Carla M. Canuso,
Robert A. Lasser, Ibrahim Turkoz, and Andrew Greenspan
[PDF]
Reply by Donald E. N. Addington, Christos Pantelis, Antony D. Loebel,
and Steven J. Romano
[PDF]
164 Methodological Concerns Regarding the Relation Between Mefloquine and
Serious Psychiatric Events in Females. Martin L. Tepper and Barbara A. Strauss
[PDF]
- Reply by Bruno H.Ch. Stricker
165 Propofol for Severe, Refractory Mania: A Case Report. Jeffrey S. Cluver and Susan J. Hardesty
[PDF]
166 Galantamine-Induced QTc Prolongation. Matthew W. Nelson and Robert W. Buchanan
[PDF]
Book Reviews 168